Jaguar Health Inc (NAS:JAGX)

$ 1.13 -0.04 (-3.42%) Market Cap: 10.44 Mil Enterprise Value: 28.92 Mil PE Ratio: 0 PB Ratio: 0.52 GF Score: 35/100

Q1 2024 Jaguar Health Inc Earnings Call Transcript
May 14, 2024

$16.49 (-5.30%)

Earnings
Q4 2023 Jaguar Health Inc Earnings Call Transcript
Apr 01, 2024

$4.62 (-14.35%)

Earnings
Q3 2023 Jaguar Health Inc Earnings Call Transcript
Nov 14, 2023

$19.89 (+6.94%)

Earnings
Jaguar Health Inc at Emerging Growth Conference (Virtual) Transcript
Nov 01, 2023
Q2 2023 Jaguar Health Inc Earnings Call Transcript
Aug 14, 2023

$32.09 (-6.47%)

Earnings
Ladenburg Thalmann to Host Virtual Discussion with Jaguar Health Inc Transcript
Jun 22, 2023
Jaguar Health Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
May 18, 2023
Q1 2023 Jaguar Health Inc Earnings Call Transcript
May 15, 2023

$45.52 (-22.58%)

Earnings
Q4 2022 Jaguar Health Inc Earnings Call Transcript
Mar 27, 2023

$62.4 (-7.96%)

Earnings
Jaguar Health Inc Highlight Unmet Medical Need of Cancer Therapy-related Diarrhea and Entheogen Therapeutics Initiative (ETI) - Corporate Call Transcript
Jan 12, 2023
Q3 2022 Jaguar Health Inc Earnings Call Transcript
Nov 14, 2022

$632.25 (-6.33%)

Earnings
Q2 2022 Jaguar Health Inc Earnings Call Transcript
Aug 22, 2022

$1078.2 (-10.09%)

Earnings
Q1 2022 Jaguar Health Inc Earnings Call Transcript
May 10, 2022

$1799.55 (-3.29%)

Earnings
Q4 2021 Jaguar Health Inc Earnings Call Transcript
Mar 14, 2022

$1697.85 (-3.26%)

Earnings
Q3 2021 Jaguar Health Inc Earnings Call Transcript
Nov 17, 2021

$7290 (-6.90%)

Earnings
Jaguar Health Inc at Ladenburg Thalmann R&D Webinar Transcript
Sep 29, 2021
Jaguar Health Inc Appoints Karen Brunke Corporate Update Call Transcript
Sep 20, 2021
Q2 2021 Jaguar Health Inc Earnings Call Transcript
Aug 13, 2021

$16740.02 (-6.77%)

Earnings
Jaguar Health Inc Business Update Call Transcript
Jul 29, 2021
Jaguar Health Inc Innovators with Jane King Webcast Transcript
Jun 03, 2021
Q1 2021 Jaguar Health Inc Earnings Presentation Transcript
May 17, 2021
Jaguar Health Inc Napo EU Business Overview Corporate Call Transcript
Apr 23, 2021
Jaguar Health, Inc. - Special Call Transcript
Jan 27, 2021
Jaguar Health, Inc. - Special Call Transcript
Jan 14, 2021
Jaguar Health, Inc. - Special Call Transcript
Dec 17, 2020
Q3 2020 Jaguar Health Inc Earnings Call Transcript
Nov 16, 2020

$2632.5 (-3.47%)

Earnings
Jaguar Health, Inc. - Special Call Transcript
Oct 20, 2020
Q2 2020 Jaguar Health Inc Earnings Call Transcript
Aug 13, 2020

$7468.21 (-13.47%)

Earnings
Q1 2020 Jaguar Health Inc Earnings Call Transcript
May 15, 2020

$6647.41 (-2.88%)

Earnings
Q4 2019 Jaguar Health Inc Earnings Call Transcript
Apr 06, 2020

$6482.71 (-4.91%)

Earnings
Jaguar Health Inc to Discuss Interim Analysis of HALT-D Study of Mytesi (Crofelemer) and Business Updates Conference Call Transcript
Nov 14, 2019
Jaguar Health, Inc. - Special Call Transcript
Oct 03, 2019

Jaguar Health Inc at Ladenburg Thalmann R&D Webinar Transcript

Sep 29, 2021 / 05:00PM GMT

Release Date Price: $9630 (-4.46%)

Transcript

Destiny Alexandra Hance Buch

Ladenburg Thalmann & Co. Inc., Research Division - Analyst

Hello, and welcome to Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight company products in the clinical or regulatory process. Today, we are excited to highlight Jaguar Health, and we'll turn it over to management in a moment.

We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded, and intended for the investment community. We'd also like to note the risks associated with owning shares of Jaguar Health. If you have any questions or concerns, please contact me, Destiny Hance at [email protected].

Without further ado, I will turn it over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?

Jeffrey Scott Cohen

Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research

Thank you, Destiny, and thank you, everyone for joining us. Today, we're going to be speaking with both Lisa Conte, CEO of Jaguar Health; as well as

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.